GE HealthCare (GEHC) announced a strategic evolution to its operations and executive leadership team to help shape the company’s next chapter of growth and better serve patients and customers globally. The changes will also position the company to enhance execution, accelerate innovation, and create efficiencies. These changes are effective immediately. Phil Rackliffe has been appointed President and Chief Executive Officer of Advanced Imaging Solutions, a new segment that combines Imaging and Advanced Visualization Solutions to create a $14.6 billion segment. This combination brings together GE HealthCare’s two largest segments to create a more focused and connected end-to-end imaging ecosystem spanning diagnosis, intervention, and follow-up across disease states. AIS includes an AI-enabled portfolio of MR, CT, Molecular Imaging, Women’s Health, X-ray, Ultrasound, Image-guided solutions, and enterprise imaging. These solutions enable more seamless workflows, faster and more precise decision-making, and real-time procedural support. Pharmaceutical Diagnostics and Patient Care Solutions will continue to operate as separate segments. Catherine Estrampes has been appointed Chief Commercial and Growth Officer for GE HealthCare and will lead Global Markets, a new region that encompasses every market except for China, which continues to be led by Will Song. The creation of Global Markets will strengthen how commercial teams build and scale expertise across markets and bring the full portfolio to customers globally.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- GE HealthCare announces first patient dosed in Phase 2/3 LUMINA trial
- GE HealthCare price target lowered to $88 from $96 at Piper Sandler
- GE HealthCare expands mammography collaboration with DeepHealth
- GE HealthCare price target lowered to $90 from $95 at Mizuho
